Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance

Margaret L. Dahn; Brianne M. Cruickshank; Ainsleigh J. Jackson; Cheryl Dean; Ryan W. Holloway; Steven R. Hall; Krysta M. Coyle; Hillary Maillet; David M. Waisman; Kerry B. Goralski; Carman A. Giacomantonio; Ian C.G. Weaver; Paola Marcato

doi:10.1158/1535-7163.MCT-19-0745

Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance

Margaret L. Dahn, Brianne M. Cruickshank, Ainsleigh J. Jackson, Cheryl Dean, Ryan W. Holloway, Steven R. Hall, Krysta M. Coyle, Hillary Maillet, David M. Waisman, Kerry B. Goralski, Carman A. Giacomantonio, Ian C.G. Weaver, Paola Marcato

Physics and Astronomy

科研成果: 期刊稿件 › 文章 › 同行评审

22 引用（Scopus）

源语言	英语
页（从-至）	1110-1122
页数	13
期刊	Molecular Cancer Therapeutics
卷	19
期	5
DOI	https://doi.org/10.1158/1535-7163.MCT-19-0745
出版状态	已出版 - 5月 1 2020

!!!ASJC Scopus Subject Areas

肿瘤学
癌症研究

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1158/1535-7163.MCT-19-0745

其它文件与链接

引用此

Dahn, M. L., Cruickshank, B. M., Jackson, A. J., Dean, C., Holloway, R. W., Hall, S. R., Coyle, K. M., Maillet, H., Waisman, D. M., Goralski, K. B., Giacomantonio, C. A., Weaver, I. C. G., & Marcato, P. (2020). Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance. Molecular Cancer Therapeutics, 19(5), 1110-1122. https://doi.org/10.1158/1535-7163.MCT-19-0745

Dahn, ML, Cruickshank, BM, Jackson, AJ, Dean, C, Holloway, RW, Hall, SR, Coyle, KM, Maillet, H, Waisman, DM, Goralski, KB, Giacomantonio, CA, Weaver, ICG & Marcato, P 2020, 'Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance', Molecular Cancer Therapeutics, 卷 19, 号码 5, 页码 1110-1122. https://doi.org/10.1158/1535-7163.MCT-19-0745

@article{69e734477fa444c89160213cb838602b,

title = "Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance",

author = "Dahn, {Margaret L.} and Cruickshank, {Brianne M.} and Jackson, {Ainsleigh J.} and Cheryl Dean and Holloway, {Ryan W.} and Hall, {Steven R.} and Coyle, {Krysta M.} and Hillary Maillet and Waisman, {David M.} and Goralski, {Kerry B.} and Giacomantonio, {Carman A.} and Weaver, {Ian C.G.} and Paola Marcato",

note = "Publisher Copyright: {\textcopyright} 2020 American Association for Cancer Research.",

year = "2020",

month = may,

day = "1",

doi = "10.1158/1535-7163.MCT-19-0745",

language = "English",

volume = "19",

pages = "1110--1122",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "5",

}

TY - JOUR

T1 - Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance

AU - Dahn, Margaret L.

AU - Cruickshank, Brianne M.

AU - Jackson, Ainsleigh J.

AU - Dean, Cheryl

AU - Holloway, Ryan W.

AU - Hall, Steven R.

AU - Coyle, Krysta M.

AU - Maillet, Hillary

AU - Waisman, David M.

AU - Goralski, Kerry B.

AU - Giacomantonio, Carman A.

AU - Weaver, Ian C.G.

AU - Marcato, Paola

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85084270673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084270673&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-19-0745

DO - 10.1158/1535-7163.MCT-19-0745

M3 - Article

C2 - 32156786

AN - SCOPUS:85084270673

SN - 1535-7163

VL - 19

SP - 1110

EP - 1122

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

IS - 5

ER -

Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此